Randy Barnes

🗞 Breaking news 🤩 Genezen acquire uniQure's commercial GT manufacturing ops in Lexington!! This strategic acquisition will enable Genezen to deliver late-phase and commercial gene therapy development and manufacturing services to customers around the world. Check out full article below👇 #CDMO #Genezen #GeneTherapy

18

🎉 Big News from NeoGenomics Laboratories! 🧬💡 NeoGenomics just secured New York State Department of Health approval for its Neo Comprehensive and NeoType DNA & RNA Lung NGS tests! 🎯 These advanced tests are now available to oncologists in New York, aiming to enhance diagnostic precision and cost-effectiveness for cancer treatment. The Neo Comprehensive panel covers 517 genes across multiple tumors, while NeoType focuses on actionable mutations in lung cancer. #CancerResearch #NGSTesting #LungCancer #PrecisionOncology #NeoGenomics #InnovationInHealthcare #Genomics #PersonalizedMedicine

5

1 Comment

The remarkable science, especially the outstanding chemistry that underpins our innovative new products, seldom receives visibility across the wider public. Yesterday was different. At last night’s gala at Bell Works in Holmdel, NJ hosted by the Research & Development Council of New Jersey, Merck & Co., Inc. was honored with the Edison Patent Award in the Animal Health category. This recognition celebrates the outstanding contributions of our talented inventors: Luke Schenck, Athanas Koynov, George zhou, and Aaron Cote. Their innovative work on a drug substance crystallization route has been pivotal in developing our latest advancement of fluralaner, providing long-lasting parasite control for dogs. Check out the video below!

170

8 Comments

Attention Life Science Professionals! 🔥 ANOTHER HOT TOPIC ALERT! 🧪🔬 Some More Good News in the Life Sciences! Check out the summary below regarding the 3,000 jobs created in Boston area in 2024. Share your thoughts in the comments! And if you are looking for folks, please let us know! hashtag #lifesciences #biotech #pharma #medicaldevice #diagnostics #hiring2024 #boston The Richmond Group USA

6

🚀 Samsung Biologics Upgrades Production Pact with Baxter International Inc. in $223M Deal! 💼 Exciting news from the biotech world! Samsung Biologics has announced an upgraded production agreement with Baxter, valued at a staggering $223 million. This collaboration marks a significant step forward in advancing biopharmaceutical manufacturing capabilities. 🔹 Deal Highlights: -Partnership Expansion: This deal strengthens the existing partnership between Samsung Biologics and Baxter, showcasing mutual commitment to excellence in biopharma production. -Financial Boost: The $223 million investment underscores the importance of scaling up production to meet growing global demand. -Innovation and Quality: Samsung Biologics continues to set industry standards with cutting-edge manufacturing processes and unwavering quality control. This upgraded pact is set to enhance biopharma production, ensuring better access to essential medicines worldwide. 🌐 #SamsungBiologics #Baxter #Biopharma #HealthcareInnovation #ProductionUpgrade #BiotechNews #PharmaIndustry #GlobalHealth #Innovation #Partnerships

4

1 Comment

Check out this white paper "Digital Transformation and Paperless CQV" by Azzur Vice President of Consulting Services, Brijesh Patel, where he provides innovative CQV insights and recommendations. Link in comments

1

1 Comment

80% of Massachusetts Bioscience graduates are being pulled into careers outside of Life Sciences! This years headlines have been dominated by layoffs, but whilst the industry continues to recover and companies begin to hire again, the demand for talent will only increase. MassBioEd CEO, Sunny Schwartz claims “Some of them may be thinking that the only option is med school". As a Biochemistry graduate who went from an MSc, straight into a career of Life Science recruitment, with the main reason being I had no idea what else was out there! Nine years on, I can safely say I made a great choice, but had I known what else was out there, maybe I would've taken a different path? How can we go about increasing the awareness of the fantastic careers that Biotech can offer for our next generation of graduates? #Biotech #lifesciences #MassBioEd

43

2 Comments

ASCM Northern New England Chapter Will be holding a virtual CPIM preparation class. The class will meet once a week from 6pm est to 10pm est. It will run Monday, September 30th to Monday, December 16th. Please PM me if interested! #CPIM #ASCM #APICS #SupplyChain

4

OPCU - Partner Week: Biotech's developing large molecule drugs should attend, finding the right outsourcing partner is critical to drug development strategy! At OPCU events, get your questions answered and find out what you need to know within your selection process of working with CDMO partners, timing , capabilities and cultural fit can all be assessed at the Outsourced Pharma Capacity Update. Just Ask for a follow up meeting after the presentation!

3

🚀 BIOPROCESSING SUMMIT 📅 Monday August 19, 12:00 PM 📍Gene Therapy CMC and Analytics Track Do not miss the opportunity to visit my Luncheon Presentation during the #CHIBioprocessingSummit in Boston: 𝗘𝗻𝗴𝗶𝗻𝗲𝗲𝗿𝗲𝗱 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻: 𝗧𝗵𝗲 𝗠𝗮𝗸𝗶𝗻𝗴-𝗢𝗳 𝗗𝗘𝗡𝗔𝗥𝗔𝗦𝗘 𝗛𝗶𝗴𝗵 𝗦𝗮𝗹𝘁 𝗳𝗼𝗿 𝗛𝗶𝗴𝗵-𝗘𝗳𝗳𝗶𝗰𝗶𝗲𝗻𝗰𝘆 𝗗𝗡𝗔 𝗥𝗲𝗺𝗼𝘃𝗮𝗹 𝗶𝗻 𝗩𝗶𝗿𝗮𝗹 𝗩𝗲𝗰𝘁𝗼𝗿 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 👇Session Objectives: 🔎 How to improve efficiency of viral vector manufacturing at elevated salt concentrations ✅ The benefits of DENARASE High Salt for DNA removal 🔬 Enzyme engineering at c-LEcta: ENESYZ Technology Platform 📣 Stop also by 𝗕𝗼𝗼𝘁𝗵 𝟱𝟬𝟳 to talk to my colleagues Tim McClain, Jay Lachance and Elena Kempf who will tell you more about 𝗗𝗘𝗡𝗔𝗥𝗔𝗦𝗘 𝗛𝗶𝗴𝗵 𝗦𝗮𝗹𝘁 and our complete toolkit for DNA removal. Cambridge Healthtech Institute #CGT #DENARASE #biopharma #ISCT2024 #enzyme #endonuclease #viralvector #bioprocessing

27

A great read for Regulatory Affairs - CMC professionals. I highly recommend this book. It dives into the technical side of CMC (Chemistry, Manufacturing, and Controls) in drug development and does a fantastic job of laying out the concepts step by step. It breaks down the CMC requirements for each phase and supports them with real-world examples from the industry. It's one of the most hands-on and practical reads you'll find on the topic.

27

1 Comment

Will we see more opportunity for Validation Professionals in 2025? The validation market is heating up as big players and industry shifts create new opportunities for CQV and Validation professionals. Here’s what’s driving the change: 📈 Biotech Expansion — With huge investments from Amgen ($1.5B), J&J ($2B), and Fujifilm Diosynth ($1.2B), demand for CQV engineers is set to rise. With many opportunities across Aseptic Processing, Equipment Validation and Automation. ⚙️ Tech-Enabled Validation — The shift to digital validation systems and paperless CQV is here. Companies are turning to cloud-based tools to streamline data capture and boost audit-readiness. 🌿 Sustainable Validation — As biopharma adopts green manufacturing, validation engineers must ensure compliance for eco-friendly production and energy-efficient systems. 💥 What’s Next? With 2025 a few weeks away I am looking to connect with CQV and Validation Consultants to discuss projects upcoming in Q1 next year. 👉 Do you think 2025 will have more opportunity that 2024? Let me know! #Validation #CQV #PharmaTrends #Biopharma #Innovation #AsepticProcessing #CellAndGeneTherapy #Sustainability

15

1 Comment

From #labcentral to #kendallsquare, nothing beats a day of client visits in the heart of #Boston #biotech Meeting people face-to-face puts it in perspective for me: >>>This market has challenged both clients and candidates. >>>Control your controllables: Patience (with yourself & others), discipline & diligence, and a positive attitude. >>>Great science 🔬 is driven by great 👩‍🔬 people 👨‍🔬. Always do your best & success will follow. Comment below with your own thoughts:👇

31

Follow the links in this post to learn more about the effort to engage with women who'd like to make a difference at Vertex.

21

Meet the #CDMO Experts in Boston for pDND, mRNA, LNP - Talk to our Scientists about YOUR Project at Boston Biotech Week!

6

As NAMs are becoming more relevant and accessible in today’s chemical product development, Labcorp is innovating in vitro alternatives so clients around the globe can leverage these new assays. From standard techniques to novel solutions, we can identify an approach that fits your product’s specific regulatory requirements. Discover your NAM options today. #CropProtection #ChemicalDevelopment #InVitroStudyAlternatives NewApproachMethodologies #NAMs

8

For anyone building diagnostics: Very cool approach to gain valuable insights into FDA decision summaries. Brendan O'Leary scraped the FDA’s decision summaries and provided some simple R code for anyone to get up and running in no time to prod and probe those summaries. Very nice work!

25

1 Comment

Big News in the Gene Therapy World! Genezen is taking a huge step forward by acquiring uniQure’s gene therapy operations in Lexington, MA! This means they’re getting a new manufacturing facility and an amazing team, boosting their abilities from early development all the way to commercial manufacturing.🏭 Highlights: ✅ New strategic supply agreements for uniQure’s clinical projects and CSL’s HEMGENIX® – the first gene therapy for Hemophilia B approved in the US and Europe.🩸 ✅ The Lexington site will become Genezen’s global AAV center of excellence, joining forces with their Indianapolis team.🌍 ✅ Backed by extra funding from Ampersand Capital Partners, setting the stage for even more growth and innovation.💡 Steve Favaloro, Genezen’s CEO, is pumped about this acquisition, saying it perfectly aligns with their mission to push cell and gene therapies forward. Matthew Kapusta from uniQure and Michael Deem from CSL Behring are also excited about this new chapter. This is a major milestone in the gene therapy space, promising better manufacturing capabilities and support for cutting-edge treatments. #GeneTherapy https://lnkd.in/dnBtwKff

65